FORMELA JEAN FRANCOIS 4
4 · Ikena Oncology, Inc. · Filed Jun 13, 2023
Insider Transaction Report
Form 4
FORMELA JEAN FRANCOIS
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-09+17,520→ 17,520 totalExercise: $6.51Exp: 2033-06-09→ Common Stock (17,520 underlying)
Footnotes (2)
- [F1]This option shall vest in full upon the earlier of (i) June 9, 2024 or (ii) the date of the next annual meeting, all vesting shall cease if the director resigns from the Board or otherwise ceases to service as a director.
- [F2]The Reporting Person is a member of Atlas Venture Associates X, LLC and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the option to Atlas Venture Life Science Advisors, LLC. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.